FDA Inspection
University of Texas Southwestern Medical Center, TheUniversity of Texas Southwestern Medical Center, The – FDA Inspection, Nov 9, 2018
Record Details
This FDA Inspection record concerns University of Texas Southwestern Medical Center, The, with an inspection on November 9, 2018, issued by the Dallas District Office, covering human drugs.
- Inspection Date
- November 9, 2018
- Product Type
- Human Drugs
- Office
- Dallas District Office
- People
- Jason R. Caballero (FDA Associated Person)
- Reba A. Gates (Issuing Officer)
View Company Profile
ID · de0bff08-986e-41a1-a13d-0fb2ba2bd652
Inspection Facts
- Inspection number
- 1073752
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of University of Texas Southwestern Medical Center, The
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| February 9, 2023 | Not classified | Dallas District Office | |
| September 13, 2019 | Not classified | Dallas District Office | |
| August 2, 2017 | OAI | Dallas District Office | Generic Drug Evaluation |
| October 20, 2015 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for University of Texas Southwestern Medical Center, The
- FDA Inspection 1317258 - 2026-05-15
- FDA Inspection 1198460 - 2023-02-09
- FDA Inspection 1101987 - 2019-09-13
- FDA Inspection 1021093 - 2017-08-02
- FDA Inspection 946171 - 2015-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.